Results 81 to 90 of about 4,757 (93)

The role of cytochrome P450 genetic variants in pesticide metabolism and the risk of child neurodevelopment: a systematic review. [PDF]

Front Pediatr
Chilipweli PM, Kidenya BR, Nyanza EC, Ngowi AV, Manji K.   +4 more
europepmc   +1 more source

Pharmacogenomic Calling From Whole-Exome Sequencing in the Taiwanese Population-A Real-World Experience. [PDF]

Mol Genet Genomic Med
Lin HH, Tsai MM, Chen HA, Hsu RH, Lin YS, Lin YL, Hsu C, Chien YH, Hwu WL, Lee NC.   +9 more
europepmc   +1 more source

Flavonoids and Furanocoumarins Involved in Drug Interactions. [PDF]

Molecules
Berteina-Raboin S.
europepmc   +1 more source

Profiling the Tox21 Compound Library for Their Inhibitory Effects on Cytochrome P450 Enzymes. [PDF]

Int J Mol Sci
Sakamuru S, Travers J, Klumpp-Thomas C, Huang R, Witt KL, Ferguson SS, Simmons SO, Reif DM, Simeonov A, Xia M.   +9 more
europepmc   +1 more source

Voriconazole-induced Hypoglycemia in a Non-diabetic Patient: A Rare Cause. [PDF]

Clin Med Res
Patel GR, Singh V.
europepmc   +1 more source

Dynamic modelling of liver-bone axis: A microphysiological approach to hepatic osteodystrophy. [PDF]

Bioact Mater
Gupta P, Mehrotra S, Aspera-Werz RH, Mairal A, Pandit AH, Nüssler AK, Kumar A.   +6 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Modeling to Assess Perpetrator and Victim Cytochrome P450 2C Induction Risk. [PDF]

Pharmaceutics
Slavsky M, Karve AS, Hariparsad N.
europepmc   +1 more source

Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practice. [PDF]

JAMIA Open
Massmann A, Petry NJ, Weaver M, Brady H, Lupu RA.   +4 more
europepmc   +1 more source

Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liver.

Pharmacol Res
Klein K, Burk O, Tremmel R, Buettner FA, Kaestle L, Schroth W, Muerdter TE, Eccles D, Schmidt AC, Nieß H, Zanger UM, Schwab M, Lauschke VM.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients

Pathologie Biologie, 2013
Coumarin derivatives such as acenocoumarol represent the therapy of choice for the long-term treatment and prevention of thromboembolic diseases. Many genetics determinants involved in the metabolism of acenocoumarol have been shown to influence the anticoagulant dosage.
F Z, Smires, R, Habbal, C, Moreau, A, Assaidi, M A, Loriot, S, Nadifi   +5 more
openaire   +2 more sources